InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Lustig Marc. Officer active across 1 company, notably BriaCell Therapeutics Corp.. Aggregated, 1 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1.8m. History available since 14 May 2024. The latest transaction was filed on 14 May 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration